陳 俊興

Medicine & Life Sciences

1. Schizophrenia 100%
2. Olanzapine 41%
3. Alcoholism 39%
4. Antipsychotic Agents 37%
5. Metabolic Syndrome 37%
6. Clozapine 36%
7. Alcohols 31%
8. Major Depressive Disorder 30%
9. Delirium 28%
10. Psychotic Disorders 24%
11. Depression 23%
12. Meta-Analysis 21%
13. Placebos 20%
14. desmethylolanzapine 19%
15. Alcoholics 18%
16. Ketamine 18%
17. Metformin 17%
18. Psychopathology 17%
19. Alcohol Withdrawal Delirium 16%
20. Orexins 16%
21. Adiponectin 13%
22. Serum 13%
23. Mood Disorders 12%
24. Hyperprolactinemia 12%
25. Therapeutics 12%
26. Energy Drinks 12%
27. Cognition 12%
28. Randomized Controlled Trials 11%
29. Malondialdehyde 11%
30. Antidepressive Agents 11%
31. Inpatients 11%
32. Treatment-Resistant Depressive Disorder 11%
33. Insulin Secretion 9%
34. Oxidative Stress 9%
35. Methamphetamine 9%
36. Bipolar Disorder 9%
37. Omega-3 Fatty Acids 9%
38. Aripiprazole 9%
39. Brain-Derived Neurotrophic Factor 8%
40. Metabolome 8%
41. Craving 8%
42. Alleles 8%
43. Genes 8%
44. General Hospitals 8%
45. Body Weight 8%
46. DNA Damage 7%
47. Statistical Factor Analysis 7%
48. Sleep 7%
49. Fluvoxamine 7%
50. 8-Hydroxy-2'-Deoxyguanosine 7%